阿伐他汀
7-[2-(4-fluorophenyl)-3-phenyl-4-(phenylcarbamoyl)-5-propan-2-ylpyrrol-1-yl]-3,5-dihydroxyheptanoic acid
阿伐他汀;(3S,5S)-7-[2-(4-氟苯基)-3-苯基-4-(苯基氨基甲酰基)-5-异丙基吡咯-1-基]-3,5-二羟基庚酸;(r*,r*)-2-(4-氟苯基)-,d-二羟基-5-(1-甲基乙基)-3-苯基-4-[(苯基氨基)羰基]-1H-吡咯-1-庚酸;5-乙氧基吲哚;Atorvastatin 阿伐他汀;阿托伐他汀;阿托伐他汀(阿伐他汀);(rel)-阿托伐他汀 阿伐他汀;(3S,5S)-7-[2-(4-氟苯基)-3-苯基-4-(苯基氨基甲酰基)-5-异丙基吡咯-1-基]-3,5-二羟基庚酸;(r*,r*)-2-(4-氟苯基)-,d-二羟基-5-(1-甲基乙基)-3-苯基-4-[(苯基氨基)羰基]-1H-吡咯-1-庚酸;5-乙氧基吲哚;Atorvastatin 阿伐他汀;阿托伐他汀;阿托伐他汀(阿伐他汀);(rel)-阿托伐他汀 展开
110862-48-1
C₃₃H₃₅FN₂O₅
558.64
中文名称 阿伐他汀
中文别名 阿伐他汀;(3S,5S)-7-[2-(4-氟苯基)-3-苯基-4-(苯基氨基甲酰基)-5-异丙基吡咯-1-基]-3,5-二羟基庚酸;(r*,r*)-2-(4-氟苯基)-,d-二羟基-5-(1-甲基乙基)-3-苯基-4-[(苯基氨基)羰基]-1H-吡咯-1-庚酸;5-乙氧基吲哚;Atorvastatin 阿伐他汀;阿托伐他汀;阿托伐他汀(阿伐他汀);(rel)-阿托伐他汀
英文名称 7-[2-(4-fluorophenyl)-3-phenyl-4-(phenylcarbamoyl)-5-propan-2-ylpyrrol-1-yl]-3,5-dihydroxyheptanoic acid
英文别名 Atorvastatin;1H-Pyrrole-1-heptanoic acid, 2-(4-fluorophenyl)-β,δ-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-, (βR,δR)-rel-;1H-PYRROLE-1-HEPTANOIC ACID;(3S,5S)-7-[2-(4-Fluorophenyl)-3-phenyl-4-(phenylcarbamoyl)-5-propan-2-ylpyrrol-1-yl]-3,5-dihydroxyheptanoic acid;Atorvastatin calciuM;Atorvastatin(Relative);(rel)-Atorvastatin;HSDB 7039;rel-Atorvastatin;Atorvastatin (Relative Stereo);ATORVASTATIN [VANDF];(3R,5R)-7-[2-(4-fluorophenyl)-3-phenyl-4-(phenylcarbamoyl)-5-propan-2-ylpyrrol-1-yl]-3,5-dihydroxyheptanoic acid;134523-03-8;Tozalip;Atorlip;Cardyl;(betaR,deltaR)-2-(p-Fluorophenyl)-beta,delta-dihydroxy-5-isopropyl-3-phenyl-4-(phenylcarbamoyl)-pyrrole-1-heptanoic Acid;HMS3715L05;C10AA05;Atorvastatin (INN);NCGC00159458-02;BRD-K69726342-001-02-6;ATORVASTATIN [HSDB];NCGC00159458-03;MRF-0000761;Sortis (TN);Tox21_302417;CCRIS 7159;Q668093;AKOS000281127;(3R,5R)-7-[2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4-phenylcarbamoyl-pyrrol-1-yl]-3,5-dihydroxy-heptanoic acid;MFCD00899261;A806793;C06834;DB01076;NCGC00159458-20;sodium 7-[5-(4-fluorophenyl)-2-isopropyl-4-phenyl-3-(phenylcarbamoyl)-2,3-dihydropyrrol-1-yl]-3,5-dihydroxy-heptanoate;Lipitor;atorvastatina;CAS-134523-00-5;BDBM22164;(3R,5R)-7-(3-(anilinocarbonyl)-5-(4-fluorophenyl)-4-phenyl-2-(propan-2-yl)-1H-pyrrol-1-yl)-3,5-dihydroxyheptanoic acid;(3R,5R)-7-(2-(4-Fluorophenyl)-5-isopropyl-3-phenyl-4-(phenylcarbamoyl)-1H-pyrrol-1-yl)-3,5-dihydroxyheptanoic acid;Lipilou;(3R,5R)-7-[2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4-(phenylcarbamoyl)pyrrol-1-yl]-3,5-dihydroxy-heptanoic acid;atorvastatin;CHEMBL1487;SR-01000872702;(3R,5R)-7-[2-(4-fluorophenyl)-3-phenyl-4-(phenylcarbamoyl)-5-(propan-2-yl)-1H-pyrrol-1-yl]-3,5-dihydroxyheptanoic acid;Atorvastatin calcium salt;134523-00-5;Ator;Lipilou; Tozalip; Torvast; Cardyl;DTXSID8029868;A802259;GTPL2949;SCHEMBL3831;1H-Pyrrole-1-heptanoic acid, 2-(4-fluorophenyl)-beta,delta-dihydroxy-5-(1-methylethyl)-3-phenyl-4-((phenylamino)carbonyl)-, (R-(R*,R*))-;HY-B0589;Atorcor;1H-Pyrrole-1-heptanoic acid, 2-(4-fluorophenyl)-beta,delta-dihydroxy-5-(1-methylethyl)-3-phenyl-4-((phenylamino)carbonyl)-, (betaR,deltaR)-;BIDD:GT0336;AS-35260;(3R,5R)-7-[2-(4-Fluorophenyl)-5-isopropyl-3-phenyl-4-phenylcarbamoylpyrrol-1-yl]-3,5-dihydroxyheptanoic acid;Atorvastatin & Primycin;CI 981;(betaR,deltaR)-2-(p-Fluorophenyl)-beta,delta-dihydroxy-5-isopropyl-3-phenyl-4-(phenylcarbamoyl)pyrrole-1-heptanoic acid;atrovastin;Lipinon;CI-981;ATORVASTATIN [MI];ATORVASTATIN CALCIUM;Atorvastatin [INN:BAN];7-[2-(4-FLUORO-PHENYL)-5-ISOPROPYL-3-PHENYL-4-PHENYLCARBAMOYL-PYRROL-1-YL]- 3,5-DIHYDROXY-HEPTANOIC ACID;atorvastatinum;D07474;ATORVASTATIN [WHO-DD];atorvastatine;Atofast;(3R,5R)-7-[2-(4-fluorophenyl)-5-(1-methylethyl)-3-phenyl-4-(phenylcarbamoyl)-1H-pyrrol-1-yl]-3,5-dihydroxyheptanoic acid;(R-(R*,R*))-2-(4-Fluorophenyl)-beta,delta-dihydroxy-5-(1-methylethyl)-3-phenyl-4-((ph...
CAS No. 110862-48-1
分子式 C₃₃H₃₅FN₂O₅
分子量 558.64
象形图
警示语
Class
警告声明
UNub
危险声明
Packing Group
搜索质检报告(COA)
搜索MSDS